Multi-Modal Omics & Radiomics Pipelines: From Raw Medical Data to Predictive RWE Models

Healthcare AI · Radiomics · Real-world evidence

Multi-modal fusion of radiomics, genomics and AI pipelines

Multi-modal data fusion: imaging + omics → predictive RWE models

Quantitative medical imaging and molecular datasets contain dense, sub-visual biological signals capable of predicting therapeutic response, gene mutations, and overall survival in oncology. Transforming these high-dimensional, unstructured datasets into validated, production-grade Real-World Evidence (RWE) models requires rigorous data engineering, standardized feature extraction, and privacy-first machine learning architectures.

The Technical Challenge

Building clinical-grade predictive models from medical imaging and multi-omics data presents several critical engineering hurdles:

Scanner & Center Heterogeneity: Variations in scanner hardware, acquisition protocols, and reconstruction parameters introduce severe batch effects and non-biological noise across datasets.
High-Dimensionality (“Curse of Dimensionality”): Automated feature extraction generates thousands of candidate variables (intensity, shape, texture, deep network embeddings) relative to limited patient cohorts, requiring strict feature selection to prevent overfitting.
Data Silos & Privacy Constraints: Strict data protection regulations prevent centralized pooling of sensitive clinical images and electronic health records (EHR) across multicenter research networks.

Modus Data Engineering Capabilities

At Modus Data, we design and deploy scalable data architectures, feature extraction pipelines, and machine learning models tailored for complex biomedical applications. Our expertise bridges raw clinical data and actionable predictive insights:

1. End-to-End Feature Extraction Pipelines

Automated Image Pre-Processing: Standardized 3D/4D workflows for image resampling, intensity normalization, voxel filtering, and noise reduction.
IBSI-Compliant Extraction: Automated extraction of handcrafted radiomic features (first-order statistics, GLCM, GLRLM, NGTDM texture matrices, and wavelet transforms) fully aligned with Image Biomarker Standardization Initiative (IBSI) guidelines.
Deep Feature Engineering: Leveraging Convolutional Neural Networks (CNNs) and vision models to extract abstract spatial features directly from region-of-interest (ROI) volumes.

Radiomics and multi-omics feature extraction and fusion pipeline

End-to-end radiomics + multi-modal fusion pipeline

2. Feature Selection & Robustness Modeling

Multi-Stage Feature Reduction: Robust pipeline integration utilizing test-retest stability screening, variance filtering, and embedded regularization methods (e.g., LASSO, Elastic Net, Random Forests).
Harmonization & Batch Correction: Implementation of domain-harmonization algorithms to remove inter-scanner variability, ensuring model generalizability across independent external validation cohorts.

Data Integration Architectures: Harmonizing structural imaging (CT, MRI) and functional imaging (PET, DECT) with clinical covariates, genomic mutations (e.g., EGFR, ALK, PD-L1), and longitudinal EHR data.
Predictive Risk Scoring: Constructing unified ML/DL models and nomograms to evaluate treatment susceptibility (immunotherapy, targeted therapies) and long-term clinical outcomes.

4. Privacy-Preserving Federated Learning

Distributed AI Infrastructure: Deploying federated learning frameworks that enable multi-institutional model training without sensitive patient data ever leaving local hospital firewalls.

Privacy-preserving federated learning across hospitals

Federated learning: models travel, data stays local

Real-World Impact

By formalizing complex biomedical data into reproducible engineering pipelines, Modus Data enables pharmaceutical, biotech, and digital health organizations to:

Identify non-invasive digital biomarkers from routine standard-of-care imaging.
Accelerate real-world evidence (RWE) generation for clinical trial design and post-market surveillance.
Transition complex machine learning research into validated, enterprise-ready software platforms.

Partner with Modus Data

Looking to build, scale, or validate multi-modal AI and omics pipelines for your healthtech platform or clinical studies? Contact Modus Data to discuss your architecture.